Skip to main content
. 2022 Feb 25;6(5):1420–1431. doi: 10.1182/bloodadvances.2021006208

Figure 1.

Figure 1.

OS at 5 years for patients with TCL and NK/TCL enrolled in COMPLETE relative to people with HIV with TCL and NK/TCL and A-BCL enrolled in NA-ACCORD. Kaplan-Meier analysis of (A) OS for all mature patients with TCL and NK/TCL with and without HIV, (B) OS for all patients with ALCL with and without HIV, (C) OS for all patients with TCL and NK/TCL stratified by CD4 cell count in cells/µL and viral load in copies/mL, and (D) OS for all mature patients with TCL and NK/TCL and A-BCLs stratified by subtype.